<DOC>
	<DOCNO>NCT01959074</DOCNO>
	<brief_summary>This study To confirm efficacy Naftopidil reduce discomfort ureteral stent urinary stone surgery .</brief_summary>
	<brief_title>The Effect Naftopidil Double-J Stent Discomfort</brief_title>
	<detailed_description>1 . Enrollment 1. patient underwent Double-J ureteral stent indwell urological surgery le 15 day 2. patient age 20 year 2 . Randomization 1. naftopidil 75 mg qd placebo Double-J stent removal 2 . Standard treatment pain-killers demand also apply . ( aceclofenac ) 3 . Follow-up day Double-J stent removal ( Evaluation do stent removal )</detailed_description>
	<mesh_term>Aceclofenac</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Naftopidil</mesh_term>
	<criteria>Patients undergone doubleJ stent indwell &gt; = 20 year undergoing unilateral retrograde double J ( DJ ) stent placement plan 515 day indwell percutaneous nephrolithotomy , open laparoscopic ureterolithotomy presence ureteral stone renal insufficiency ( serum Cr &gt; 1.4 ) febrile urinary tract infection ( fever &gt; 38.0Â°C , evidence urinary infection ) pregnancy breast feed solitary kidney hypersensitivity Naftopidil current use alpha blocker , calcium channel blocker , corticosteroid moderate sever cardiovascular cerebrovascular disease hepatic dysfunction prior history pelvic surgery irradiation prior history transurethral resection bladder tumor prostate surgery significant active medical illness opinion investigator would preclude protocol treatment genetic disorder ad galactose intolerance , lapp lactase deficiency , glucosegalactose malabsorption</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>